Captain Study: Evaluating the Efficacy of Once-Daily, Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus FF/VI in Inadequately Controlled Asthma Using Change in Asthma Control Questionnaire and the Relationship with Trough FEV1

被引:0
|
作者
Fowler, A. [1 ]
Kerstjens, H. [2 ,3 ]
Bailes, Z. [1 ]
Tabberer, M. [1 ]
Barnes, N. [4 ,5 ,6 ,7 ]
Peachey, G. [1 ]
Oppenheimer, J. [8 ]
Lee, L. [9 ]
机构
[1] GSK, Stockley Pk West, Uxbridge, Middx, England
[2] Univ Groningen, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] GSK, Brentford, England
[5] Barts & London Queen Marys Sch Med & Dent, Brentford, England
[6] GSK, London, England
[7] Barts & London Queen Marys Sch Med & Dent, London, England
[8] Rutgers New Jersey Med Sch, Newark, NJ USA
[9] GSK, Collegeville, PA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5626
引用
收藏
页数:2
相关论文
共 22 条
  • [21] Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
    Kerstjens, Huib A. M.
    Maspero, Jorge
    Chapman, Kenneth R.
    van Zyl-Smit, Richard N.
    Hosoe, Motoi
    Tanase, Ana-Maria
    Lavecchia, Catherine
    Pethe, Abhijit
    Shu, Xu
    D'Andrea, Peter
    LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : 1000 - 1012
  • [22] Assessment of Cortisol Levels with Once-Daily, Single-Inhaler Mometasone-Indacaterol-Glycopyrronium versus Mometasone-Indacaterol or Twice-Daily Fluticasone-Salmeterol in Patients with Inadequately Controlled Asthma: Post Hoc Analysis from the IRIDIUM Study
    Kerstjens, H. A. M.
    Van Zyl-Smit, R.
    D'Andrea, P.
    Hosoe, M.
    Pethe, A.
    Tanase, A-M
    Jain, D. K.
    Nikolaev, I
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)